BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.12 USD | +2.17% |
|
-0.28% | -19.85% |
| 06-02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
| 06-02 | GSK blood cancer drug nearly halves risk of death in late-stage trial | RE |
